La Jolla, CA, United States of America

Catriona Helen M Jamieson

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 89(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2007 - 2009)
  • La Jolla, CA (US) (2009 - 2012)

Company Filing History:


Years Active: 2007-2012

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Catriona Helen M Jamieson in Leukemia Research**

Introduction

Catriona Helen M Jamieson is a prominent inventor based in La Jolla, California, known for her groundbreaking work in the field of leukemia research. With a remarkable portfolio of five patents, her innovations are making significant strides in understanding and treating this complex disease.

Latest Patents

Jamieson's latest patents focus on the methods for phenotyping leukemias and the identification, isolation, and elimination of cancer stem cells. These patents detail the provision of isolated populations of leukemic stem cells, which are crucial for experimental evaluation and the discovery of factors that can impact these cells. Her work emphasizes the importance of detecting leukemic stem cells for predicting disease progression, relapse, and potential drug resistance. She has also explored methods to inhibit the proliferation of leukemic stem cells through interference with the activation of the β-catenin pathway. Additionally, her patents describe techniques for clinically staging pre-leukemia and leukemias by analyzing hematologic samples for various stem and progenitor cell subsets.

Career Highlights

Catriona Helen M Jamieson is affiliated with the prestigious Leland Stanford Junior University, where she contributes her expertise to ongoing research initiatives. Her dedication to advancing leukemia research has positioned her as a leading figure in her field, exemplifying the potential of innovative scientific research in developing effective treatments.

Collaborations

Throughout her career, Jamieson has collaborated with notable peers such as Irving L Weissman and Laurie Elizabeth Ailles. These collaborations highlight her commitment to fostering teamwork in scientific exploration and innovation, which is essential for tackling complex medical challenges like leukemia.

Conclusion

Catriona Helen M Jamieson's contributions to leukemia research through her patented innovations represent significant advancements in the understanding and treatment of this disease. Her work not only enhances scientific knowledge but also opens new avenues for improving patient outcomes. As she continues her research at Leland Stanford Junior University, her efforts are likely to catalyze further innovations in the fight against leukemia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…